KOSUNI CRYPTO
Korea's Crypto Pulse, in English
$BTC $ETH $XRP $SOL $DOGE
News
Neutral

Iambic Therapeutics Secures $150 Million in U.S. IPO with NVIDIA Investment

Published October 15, 2026 12:12 PM · 4 views $IAM
Iambic Therapeutics Secures $150 Million in U.S. IPO with NVIDIA Investment

Iambic Therapeutics (Iambic Therapeutics), an AI-driven pharmaceutical company with a stake held by NVIDIA, has secured $150 million in a U.S. initial public offering. Bloomberg reported that Iambic offered approximately 9.38 million shares at $16 per share, landing at the midpoint of its targeted range of $15 to $17. The IPO valuation stands at roughly $758 million (approximately $1.157 billion), with trading set to begin on NASDAQ under the ticker IAM on October 15.

Korean Source

This article is an English localization of a Korean-language crypto news report. Original headline: 엔비디아 투자 AI 신약사 아이앰빅, IPO로 2010억원 조달